Adjuvant zoledronic acid to treat breast cancer: not for all

Costa Luis; Ferreira Arlindo R.

首页> 外文期刊>The lancet oncology >Adjuvant zoledronic acid to treat breast cancer: not for all

【24h】

Adjuvant zoledronic acid to treat breast cancer: not for all

机译：佐剂zoledronic酸治疗乳腺癌：不适合所有

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2017年第11期|共4页
作者
Costa Luis; Ferreira Arlindo R.;
展开▼
作者单位

Univ Lisbon Hosp Santa Maria Fac Med Inst Med Mol Oncol Div P-1649035 Lisbon Portugal;

Univ Lisbon Hosp Santa Maria Fac Med Inst Med Mol Oncol Div P-1649035 Lisbon Portugal;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Adjuvant zoledronic acid to treat breast cancer: not for all [J] . Costa Luis, Ferreira Arlindo R. The lancet oncology . 2017,第11期

机译：佐剂zoledronic酸治疗乳腺癌：不适合所有
2. Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 [J] . Gnant M., Mlineritsch B., Stoeger H., Annals of oncology: official journal of the European Society for Medical Oncology . 2015,第2期

机译：唑来膦酸联合他莫昔芬与阿那曲唑联合辅助内分泌治疗对绝经前早期乳腺癌的卵巢功能抑制：奥地利乳腺癌和结直肠癌研究组试验的最终分析12
3. Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: Implications for adjuvant therapy of breast cancer [J] . GalloM., DeLucaA., LamuraL., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第3期

机译：唑来膦酸阻断间充质干细胞与乳腺癌细胞之间的相互作用：对乳腺癌辅助治疗的意义
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Effect of Zoledronic Acid on Transcriptome of Cell Lines Representing Triple Negative Compared with Luminal Breast Cancer [D] . Abraham, Nissi Mygodis 2018

机译：唑来膦酸对发光性乳腺癌三联阴性细胞系转录组的影响
6. Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) [O] . R.E. Coleman, M. Collinson, W. Gregory, 2018

机译：唑来膦酸辅助治疗II / III期乳腺癌的益处和风险。 AZURE随机临床试验的10年随访（BIG 01/04）
7. Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study [O] . C. Wilson, R. Bell, S. Hinsley, 2018

机译：佐剂Zoledronic酸可减少乳腺癌患者的骨折; Azure（Big 01/04）研究

Adjuvant zoledronic acid to treat breast cancer: not for all

著录项

相似文献

相关主题

期刊订阅